Abstract
the detection of micro-organisms in blood, leading to the diagnosis of bacteraemia and sepsis. 1 The period of time within which the infection and the patient can both be successfully treated is known as the 'therapeutic window'. There comes a point outside this window period at which, even though the infection may be eradicated, the patient will not survive due to irreversible organ damage. 3 Kumar et al, report a 7.6% mean decrease in survival for every hour that effective treatment is delayed following documented hypotension in septic shock. 3,4,5 Empiric broad spectrum antimicrobial therapy is initiated immediately when there is a clinical suspicion of sepsis..
3
However whilst effective, broad spectrum antimicrobial therapy is also associated with adverse effects, for example, Clostridium difficile associated disease. Itcan also potentially contribute to the selection of multidrug resistant organisms. 3, 6 Antibiotic resistance amongst pathogens (particularly gram negative) is the most common cause of empirical treatment failure in bloodstream infection and sepsis. 2 Early diagnosis and initiation of appropriate antibiotic treatment together with earlier de-escalation of broad spectrum antibiotics is critical to improve patient outcome 2,3,7, Bearing this in mind, there is an onus on clinical microbiology laboratories to provide a more rapid robust identification and susceptibility testing system for the diagnosis of sepsis. 
Materials and Methods
All consecutive blood culture bottles which were flagged as positive by the BacTalert 3D continuous blood culture monitoring system (bioMerieux, Bruz, France), over a 3 month period (November 2013 -February 2014) were analyzed in this study.
Rapid identification (rID)
Each positive bottle was subcultured according to our routine laboratory procedure. Agar plates were incubated at 37 o C in an atmosphere containing 5% CO 2. One blood agar plate was also incubated at 37 o C in an anaerobic atmosphere. Plates were reviewed after 4 to 6 hours incubation and examined for growth. Identification When a result of 'no reliable identification' or 'no peaks found' was obtained mass spectrometry was repeated after overnight incubation For species where there were less than 10 spectra in the database, testing was done in duplicate. Results were also confirmed using Api 
Rapid Antimicrobial Susceptibility testing (rAST)
Antimicrobial susceptibility testing (AST) was performed by standardized disk diffusion methodology using the Clinical and Laboratory Standards Institute (CLSI) guidelines. 10, 11 The method was modified for the purpose of rAST by preparing an inoculum, equivalent to 0.5 McFarland (1x10 8cfu/ml ),using a Densi-CHEK densiometer (bioMerieux), from the light growth visible after 4 to 6 hours incubation ( Fig.1 (i) For each organism/antibiotic combination , 3 inoculums (0.5 McFarland) were prepared. Serial ten-fold dilutions in normal saline were performed to obtain a concentration of 1 x 10 6 cfu/ml. 28 1ml of each suspension was inoculated into the relevant BacTalert blood culture bottle. 5mls of lysed horse blood (Oxoid) was then added to each bottle. 6 Bottles were incubated on the BacTalert 3D system until they flagged positive. The rapid and standard AST methods were then repeated, as described above and confirmed by MIC testing using Etest, If at least two of the three results gave the same categorical agreement, the error could be deemed resolved.
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Quality control
We validated the rID (including PBP2a and GenXpert assays) and rAST methods using quality control strains recommended in the CLSI guidelines. 
Clinical review of results
We performed a retrospective review of the clinical microbiologists clinical notes to determine if the information generated by the rapid methods, distinct from the information provided by gram stain alone would have an impact on the advice given to clinicians regarding the management of bacteraemia.
The criteria for evaluation in this analysis were; a) no mix on gram stain or culture b) first episode of bacteraemia c) the patient was alive at the time of culture positivity.
RESULTS
96% (n = 73/76) of the gram negative isolates were correctly identified from the light growth on culture after 4 to 6 hours incubation using MALDI-TOF MS ( table 2) . There were 679 antibiotic tests performed in total on the gram negative organisms in this study. The comparative analysis of the results showed 3 (0.4%) very major errors, 4 (0.6%) major errors and 46 (6.7%) minor errors. The 46 minor errors were distributed amongst all antimicrobial agents. ( Table   2 ). The 3 very major errors we observed were detected in one strain 2 very major errors and 3 major errors were resolved by the discrepancy resolution testing protocol outlined in ISO20776-2 (table   3) .1 very major error and 1 major error resolved as minor errors. g The discordant agents were CTX in 1 strain and PTZ in 1 strain.
h One strain of E.Coli did not generate a reliable identification score (<1.8) from 4-6hr culture.
This strain was identified from culture after 24hrs incubation.
i One strain of M.catarrhalis did not identify as it was a mixed culture with S.haemolyticus j One strain of P.aeruginosa did not identify as it was a mixed culture with S.capitis.
90% (n = 175/194) of the gram positive isolates were correctly identified from culture after 4 or 6 hrs incubation using MALDI-TOF MS ( table 3) .
There were 491 antibiotic susceptibility tests performed in total on the gram positive organisms. The comparative analysis of the rapid and standard AST results showed no very major, major or minor errors (table 3) . On review, we found 100% concordance for S.aureus 
Clinical review of results
Discussion
In this study we describe a method to rapidly identify significant isolates from positive blood cultures using MALDI-TOF MS. A similar method of identifying organisms from positive blood cultures using MALDI-TOF MS subsequent to short term incubation on solid medium has also been described by Idelevich al. and we report similar findings for rapid identification. clinicians.We preformed rapid disk diffusion testing by preparing the 0.5mcF inoculums from the bacterial growth after 4 to 6 hours incubation using the Clinical and laboratory Standards Institute (CLSI) methodology and compared results to the standardized CLSI method 25, 26 As no calculations were performed 24 hours is an estimated time.
To date, several studies have utilised MALDI-TOF MS for identification of microorganisms directly from positive blood cultures and demonstrated identification rates of 80% to 90%, with 59% to 95% concordance with identification results directly from culture.
2,9,29
The variability in MALDI-TOF MS performance described in the literature has been reported to be due to the various methods used for isolation of organisms from blood culture. The methods described include differential centrifugation, washing, gel based separation and protein extraction steps to isolate bacteria and remove substances that can interfere with MALDI-TOF MS analysis. 2, 17, 29, 30, 31 These procedures, whilst more rapid than our method are costly and labour
intensive and therefore more difficult use in a routine clinical microbiology laboratory. The method described in this paper is neither labour intensive nor costly, results in a relatively rapid turnaround time that is conducive to a routine microbiology laboratory workflow.
The protocol in this study involves bacterial cultures in the log phase of growth (4 to 6 hours incubation) rather than in the stationary phase found that these could be attributed to differences in inoculum density and technical interpretation of the zone diameters rather than differences in the physiological phase of the bacterial cells, as all errors were resolved by discrepancy resolution testing.
The clinical and financial benefits of rapid identification and faster antimicrobial sensitivity results have been described by other authors, therefore we did not directly examine the impact of the new protocol on patient mortality, length of stay or hospital costs. 2, 17, 27, 28, 37 In the clinical impact analysis, we reviewed the medical While some errors did occur with this method, the error rates were within acceptable limits as outlined in ISO20776-2. 27 We have introduced a 24/7 workflow scheme into our laboratory to incorporate the rMID and rAST methods described here, for positive blood cultures. This allows final blood culture results to be available within an average of 24 hours from positive blood culture, compared to approximately 48hrs with our previous methods. It also supports our hospital antimicrobial stewardship programme by facilitating earlier review and streamlining of antimicrobial therapy using the 'Start smart then focus' care bundle. 35 Other potential benefits of rapid species ID that have been reported include the optimisation of clinical outcomes, reducing costs of antimicrobial therapy and limiting the rapidly growing selection of antimicrobial resistant pathogens.
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Take home messages
Rapid laboratory results provide valuable clinical diagnostic information upon which appropriate antimicrobial therapy can be based, helping to reduce morbidity and mortality, improve patient care and reduce healthcare costs. 
